SVRA — Savara Inc
NASDAQ · Biotechnology · Biotechnology
- Latest Close
- $5.28
- 30-Day Move
- -23.7%
- Market Cap
- $1.1B
- Shares Outstanding
- 204,660,000
- P/B Ratio
- 6.04
- ROE
- -56.0%
Analyst consensus: Buy · 14 analysts
Savara Inc
A read-only Alphactor snapshot forSavara Inc. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-21
Topline snapshot
Latest Close
$5.28
30-Day Move
-23.7%
Market Cap
$1.1B
Shares Outstanding
204,660,000
P/B Ratio
6.04
ROE
-56.0%
$5.28
-23.7%last 90 delayed daily bars
90D High
$7.00
90D Low
$4.81
Avg Volume
1,897,938
Gross margin is running at 100.0%, which gives a quick read on operating quality before you open the full model.
Net margin is -4253.9%, useful for comparing SVRA against peers in Biotechnology.
SVRA is down 23.7% over the last 30 trading days shown on this page.
Latest operating income is $-33M, which helps anchor the headline ratios with an actual earnings figure.
Dark Pool Short %
84.8%
Latest Close
$5.28
30-Day Move
-23.7%
Market Cap
$1.1B
Shares Outstanding
204,660,000
P/B Ratio
6.04
ROE
-56.0%
ROA
-45.1%
Gross Margin
100.0%
Operating Margin
-4150.0%
Net Margin
-4253.9%
Debt / Equity
0.15
Current Ratio
11.85
Latest Revenue
$0
Revenue
$0
Gross Profit
--
Operating Income
$-33M
Net Income
$-32M
Gross Margin
10000.0%
Net Margin
-425385.0%
Current Ratio
11.85
Debt / Equity
0.15
Altman Z
8.98
Safe
Piotroski
2
Weak (0-3)
Cash Conversion
0.85x
Rule of 40
--
Insufficient data
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $0 | $-38M | $-38M | $-35M |
| 2023-12-31 | $0 | $-59M | $-55M | $-51M |
| 2024-12-31 | $0 | $-102M | $-96M | $-89M |
| 2025-12-31 | $0 | $-123M | $-119M | $-101M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 6,072,561 | 0.03% | 2025-12-31 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3,719,886 | 0.02% | 2026-03-31 |
| iShares Trust-iShares Russell 2000 ETF | 3,472,543 | 0.02% | 2026-02-28 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1,482,933 | 0.01% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1,372,967 | 0.01% | 2026-01-31 |
| iShares Trust-iShares Russell 2000 Growth ETF | 1,180,953 | 0.01% | 2026-02-28 |
| Principal Funds, Inc-SmallCap Growth Fund I | 933,285 | 0.00% | 2026-01-31 |
| FINANCIAL INVESTORS TRUST-Emerald Growth Fund | 798,875 | 0.00% | 2026-01-31 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Vanguard Group
Filed 2026-01-29
$61M
+20.8%
BlackRock
Filed 2024-05-10
$36M
--
Marshall Wace
Filed 2026-02-13
$27M
--
Geode Capital Management
Filed 2026-02-09
$21M
+22.3%
D.E. Shaw
Filed 2026-02-17
$10M
+348.7%
Farallon Capital
Filed 2026-02-17
$9M
--
Charles Schwab
Filed 2026-02-13
$7M
+20.5%
4.29
Consensus
Buy—
—
—
14
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.